Health Economics and Outcomes Research (HEOR) can assist healthcare decision-makers to deliver the best possible health outcomes at affordable costs. With bespoke research services across a wide range of therapeutic areas, WorkSure^® encourages HEOR excellence to improve global health decision-making and offers cutting-edge health economic analysis. WorkSure^® team specializes in HEOR studies, economic modeling, and various healthcare budget analyses to optimize healthcare resources and promotional activities. Our HEOR studies and analysis focus on the financial impact of diseases, treatments, and conditions, including both direct and indirect medical costs.

From initial commercialization through post-launch reimbursement, WorkSure^® assists in gathering scientific evidence to establish the economic and therapeutic value of the client’s product. Our services include economic modeling, systematic literature review, and country adaptations for economic models for Health Technology Assessment submission, meta-analysis, and database analysis. We partner with expert researchers to generate objective, credible real-world evidence (RWE) and insights, backed by in-depth, longitudinal real-world data. WorkSure^® accelerates evidence-based systematic reviews on very large sets of scientific literature, allowing researchers to respond to HEOR-related issues more effectively.

Using extensive global data, rigorous study design, and innovative methodology, our staff can assist in developing convincing evidence and insights to understand the gaps in the healthcare system. Through a combination of extensive domain expertise, well-established processes, and the utilization of clinical and statistical algorithms, we develop RWE. We assist decision-making in the management and financing of pharmaceutical products in the healthcare system or national health insurance programs.